The Latest in Keratoconus Treatment - Scorecard - MDSpire

The Latest in Keratoconus Treatment

  • By

  • Kenneth Beckman, MD, FACS

  • June 1, 2025

  • 7 min

Share

Clinical Scorecard: The Latest in Keratoconus Treatment

At a Glance

CategoryDetail
ConditionKeratoconus
Key MechanismsProgressive degenerative disease of the cornea leading to steepening, thinning, and irregular astigmatism.
Target PopulationTypically presents in the second or third decade of life; prevalence estimated at 1:2000.
Care SettingOptometry and ophthalmology clinics.

Key Highlights

  • Corneal crosslinking is the gold standard for limiting progression.
  • Scleral lenses have improved vision correction for keratoconus patients.
  • Early treatment is crucial to prevent progression and optimize vision.
  • New surgical techniques like CAIRS and CTAK offer less invasive options.
  • Epi-on crosslinking is under investigation to reduce complications.

Guideline-Based Recommendations

Diagnosis

  • Early identification of keratoconus by optometrists and ophthalmologists.

Management

  • Corneal crosslinking to halt progression.
  • Use of scleral lenses for vision correction.

Monitoring & Follow-up

  • Regular follow-ups to assess corneal shape and vision.

Risks

  • Corneal transplantation carries significant risks; crosslinking may not improve vision.

Patient & Prescribing Data

Patients with keratoconus, particularly those in early stages.

Combination of crosslinking and scleral lenses can significantly improve quality of life.

Clinical Best Practices

  • Initiate treatment early to prevent progression.
  • Consider scleral lenses for patients with irregular corneas.
  • Evaluate new surgical techniques for patients unable to wear contact lenses.

References

Original Source(s)

Related Content